SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-066533
Filing Date
2012-12-05
Accepted
2012-12-05 16:04:08
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v329500_10q.htm 10-Q 341826
2 EXHIBIT 31.1 v329500_ex31-1.htm EX-31.1 7899
3 EXHIBIT 31.2 v329500_ex31-2.htm EX-31.2 7763
4 EXHIBIT 32.1 v329500_ex32-1.htm EX-32.1 4321
5 EXHIBIT 32.2 v329500_ex32-2.htm EX-32.2 4385
  Complete submission text file 0001144204-12-066533.txt   1891189

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mrna-20120331.xml EX-101.INS 219365
7 XBRL TAXONOMY EXTENSION SCHEMA mrna-20120331.xsd EX-101.SCH 14800
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrna-20120331_cal.xml EX-101.CAL 32036
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrna-20120331_def.xml EX-101.DEF 13493
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20120331_lab.xml EX-101.LAB 192494
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20120331_pre.xml EX-101.PRE 83040
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 121243398
SIC: 2834 Pharmaceutical Preparations